CALL US
TODAY!
(386) 310-1334 or click here to
Get Started

Ulcerative Colitis

Woman suffering from ulcerative colitis symptoms in bedDo you know why we conduct clinical trials for ulcerative colitis? For one thing, there is still no known cure for this chronic condition, and in some cases, the available treatments just don’t help. Ulcerative colitis is complex illness that can cause long-term inflammation in parts of the digestive tract. While there are anti-inflammatory drugs and other treatments available for ulcerative colitis, sometimes this is not enough to relieve chronic symptoms caused by this inflammatory disease.

By conducting clinical trials for ulcerative colitis, we are gaining a better understanding of this chronic condition. Not only are we developing better ways to diagnose ulcerative colitis, but we are also learning how it may be prevented. If you are struggling to manage the symptoms of ulcerative colitis, then you might be the perfect candidate for one of our new clinical trials.

Like Crohn’s disease, ulcerative colitis is another common inflammatory bowel disease (IBD). This chronic condition can be quite debilitating and can lead to a number of complications which can be life-threatening in the long run. In most cases of ulcerative colitis, these symptoms take time to fully develop, rather than manifesting rapidly. Unlike Crohn’s disease, which can affect any region of the digestive tract, ulcerative colitis tends to affect a continuous stretch of colon. While this inflammatory bowel disease can be managed with a variety of treatments, there is no cure currently available.

During our upcoming ulcerative colitis clinical trial, we will be testing experimental treatments and therapies, which could involve a combination of existing medications or something completely new. The primary purpose of conducting these studies is to be able to test the safety and efficacy of these experimental treatments on human participants. This means that when you volunteer for a ulcerative colitis clinical trial in Birmingham, AL, you are helping to ensure that there will be better treatments in the near future.

Unfortunately, many doctors are not aware of the clinical trial opportunities provided in the local area, which means that patients who could really stand to benefit from enrolling are missing their opportunity. This is why we are working so hard to make that information readily available to people in the Birmingham area. There are still a whole host of misconceptions surrounding the practice of clinical research, and we are working to help dispel these misleading thought processes.

We would also like you to know that taking part in a clinical trial does not have to be a very demanding experience. Sometimes, participating in a ulcerative colitis clinical trial in Alabama is as simple as agreeing to let our researchers have a copy of your test results, but most will need you to be a little more involved with some scheduled tests and a visit to our clinic. However, all participants will be compensated for time and travel, and any study related care, including physical examinations, laboratory services and study medicines are all provided free of charge.

Ulcerative Colitis Clinical Trials in Birmingham

Achieve Clinical Research is currently conducting a wide array of clinical studies targeted towards specific medical conditions. You may be eligible to participate in one of our ulcerative colitis clinical trials and contribute to the development and approval of a new drug or treatment. As a participant, there is no cost to you at any point during the study and health insurance is not required. Browse our clinical trials being conducted now to find the study best suited for you.

 

Additional Resources for Patients with Ulcerative Colitis

Crohn’s and Colitis Foundation of America

National Digestive Diseases Information and Clearinghouse

American Gastroenterological Association

American College of Gastroenterology

If you live around Central Alabama, click here to learn more about participating in a ulcerative colitis clinical trial.